In this article ADSK DG AMD MRVL Follow your favorite stocksCREATE FREE ACCOUNT Nvidia’s A100 GPU, used to train ChatGPT and other generative AI, is shown at the demo center of Nvidia’s headquarters in Santa Clara, California, Feb. 9, 2023. Katie Tarasov Check out the companies making headlines in midday trading. Nvidia – The chipmaker’s
United States productivity increased by a 3.7% annualized rate in Q2 2023. Michael Feroli, Chief U.S. economist at JPMorgan (NYSE:JPM), wrote that expectations for a strong boost in the three-month period “offer glimmers of hope that trend productivity is picking up,” as rising investment in software and information processing will boost growth for the economy.
Interestingly, interest rates are higher in the United States since the economy is much stronger than analysts’ and economists’ forecasts. Furthermore, unemployment is below 4%, the S&P 500 grew roughly 20% this year, and economists surveyed by the Philadelphia Fed stated that GDP is projected to grow by 1.6% in Q3 2023. The rise in
As traders continue to make millions from their mother’s basements by YOLOing Nvidia (NASDAQ:NVDA) calls, a lurking threat casts a long shadow over the global financial landscape. I have a lot of fun joking about the mania in NVDA stock on social media, but the truth is none of this will ultimately matter if I’m
Market volatility has struck again. Last week, U.S. equities continued their slide in August, leaving many market-watchers wondering whether or not equities in general had reached their peak. The attributed to this precipitous decline in share prices is most likely multi-faceted. There is the Federal Reserve, which still is not sure it will pause on interest rates
Jen-Hsun Huang, CEO, Nvidia David Paul Morris | Bloomberg | Getty Images Check out the companies making headlines in the premarket. Nvidia — The chipmaker popped 7% after reporting another blowout quarter that topped Wall Street’s estimates. Nvidia also offered optimistic guidance, saying that sales will jump 170% during the current period as demand for
This might be the best time to dip your toe into solar stocks. Solar energy is one of the fastest-growing industries in the world, as more countries and companies invest in renewable sources of power to combat climate change and reduce their dependence on fossil fuels. According to the International Energy Agency, solar photovoltaic capacity
Quantum computing, a field that leverages the principles of quantum physics, has been steadily gaining traction over the years. Among the companies vying for dominance in this nascent industry, IonQ (NASDAQ:IONQ) stands out with its unique approach to quantum computing. Despite the compelling story painted by the company, however, investors should tread carefully with IONQ
Earlier this month, I gave readers the rundown on Flexible Solutions International (NYSEAMERICAN:FSI) stock, an under-the-radar “green wave” play. With a low valuation, coupled with the company’s steady growth over the past few years, on the surface FSI stock appeared to be an opportunity worth exploring. After diving into the details, more stood out, suggesting that
Interestingly, artificial intelligence and big data solutions are integral to Palantir Technologies’ (NYSE:PLTR) stock as reliance on AI grows. This is a stock that investors would expect to outperform many of the AI-adjacent stocks that have rocketed higher this year. Since the introduction of ChatGPT in November 2022, AI stocks have surged in investor interest.
Since offering a downbeat forecast early this month Advanced Micro Devices (NASDAQ:AMD) stock is down. AMD has a market cap of $174 billion, about 7.3 times revenue. Nvidia’s (NASDAQ:NVDA) dominance in the cloud, it seems, leaves AMD with only leftovers. Despite this, analysts like AMD stock almost as much as they do Nvidia, where sales
Cannabis stocks are far from creating sustainable values. There have been two instances when cannabis stocks have skyrocketed on hopes of robust growth and legalization in the last five years. However, the big rally has been followed by a deep correction. Having said this, I am bullish on a few cannabis stocks to buy and
The one constant on Wall Street is change. Just over the past three years the S&P 500 has been a roller coaster ride. While the general trend has been up, much like the long history of the broad market index, it has definitely not been in a straight line. This causes analysts to constantly attempt
Looking for the best value stocks? Tracey Ryniec, Stock Strategist at Zacks Investment Research, discusses two stocks that might be worth a closer look by value investors: Horizon Pharma Plc (HZNP) and Dean Foods (DF). Both companies have forward P/Es well below the average of the S&P 500, which is still a sky-high level of
The Dow Jones Industrial Average often called the Dow 30, is a stock market index of 30 leading U.S. publicly traded companies. Most of the 30 Dow companies are blue-chip names and widely held stocks with large market capitalizations. As such, the Dow 30 is a bellwether for the health of the overall stock market
Michael Burry, the legendary investor who famously predicted the 2008 financial crisis, parted ways with three significant stocks – leaving many to ask: Should we follow his lead? Perhaps. First on the list of Michael Burry stocks is a Chinese e-commerce giant that once seemed invincible. Unfortunately, it now faces many challenges which could greatly impact
Quantum computing has the potential to solve complex problems that are beyond the reach of classical computers. Even better, analysts at the International Data Corporation (IDC) say the global quantum computing market could be worth well over $8.6 billion by 2030. So, there’s plenty of opportunity, even for the companies still in the early stages
After a shaky start this year, energy stocks seemed to have lost their sheen in stark contrast to last year. The early disappointments led many to believe these stocks would lose momentum. However, as the saying goes, “The night is darkest just before the dawn.” The top energy stocks are finding their stride again, surging
Artificial intelligence is changing the drug-discovery process by making it much faster and cheaper. Traditionally, most biotech stock drug candidates fail. Indeed, according to Nature, “An estimated 86% of drug candidates developed between 2000 and 2015 did not meet their stated endpoints.” And the well-respected consulting firm McKinsey reported that “Today, to discover and develop a
The stock market has rewarded investors throughout the first half of the year. However, those gains appear to be slowing, and significant macroeconomic concerns suggest more pain ahead. This means there are some sorry stocks out there that you should really consider dropping before it’s too late. Student loan payments will return in September, and